JUDITH STAMBAUGH: Open Payments
NPI 1033429261 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 7 payments from 4 companies in 2025. Trend: 2023 $72 · 2024 $16 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $244 |
| Novo Nordisk Inc | 2 | $218 |
| Seqirus USA Inc | 1 | $21 |
| PFIZER INC. | 1 | $18 |
Products named: SHINGRIX, AREXVY, Wegovy, Ozempic, Fluad, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
